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Abstract
Objective-To investigate the relation between intracar4iac thrombus and blood coagulability in patients with mitral stenosis. Design-Prospective study. Cross sectional echocardiography and plasma concentrations of the D-dimer fragment of fibrin were used concurrently to detect intracardiac thrombus in patients with mitral stenosis.
Setting-Department of Medicine, National Cardiovascular Centre, Osaka, Japan. Patients-63 patients with mitral stenosis. None of them had been receiving any anticoagulants or antiplatelet agents.
Main outcome measures-Plasma concentrations of D-dimer in patients with a mobile intracardiac thrombus, those in patients with a non-mobile intracardiac thrombus, and those in patients without an intracardiac thrombus. Results-A mobile intracardiac thrombus was found in 10 patients and a nonmobile thrombus in eight. The remaining 45 patients had no intracardiac thrombi. Plasma concentrations of Ddimer in the 10 patients with a mobile thrombus were all > 300 ng/ml (mean 983-3, 95% confidence interval 498-9 to 1467-7 ng/ml) and they were significantly higher than those in the patients with a non-mobile thrombus ( To investigate this relation we used cross sectional echocardiography and we measured the plasma concentrations of D-dimer and other indices of blood coagulation concurrently in 63 patients with mitral stenosis.
Patients and methods

STUDY POPULATION
We studied 63 patients with mitral stenosis aged 53-7 (10-8) years (mean (SD)), all of whom were inpatients or outpatients at the National Cardiovascular Centre between 1 December 1987 and 31 October 1988, and 10 healthy volunteers aged 54 3 (11 9) years. None of the patients with mitral stenosis had been taking anticoagulants, antiplatelet agents, or any other drugs that influence the haematological indices. They were all free from moderate or severe mitral regurgitation as determined by colour Doppler echocardiography.4
CROSS SECTIONAL ECHOCARDIOGRAPHY
For echocardiography we used a commercially available real time, phased array system (Toshiba SSH-60A) with a 3-75 MHz transducer. Subjects were examined in the left lateral or supine position. The heart chambers, especially the left atrial cavity, were examined extensively by shifting, rotating, and tilting the transducer and by adjusting the gain control of the equipment whenever necessary. The criteria for the echocardiographic diagnosis of intracardiac thrombi have been reported elsewhere.5 A thrombus was diagnosed when an echogenic mass with a clearly defined contour was seen inside the cardiac cavity, when the endocardial surface echo of the cardiac wall could be identified, and when the mass was visualised from various positions on the chest wall. The thrombus was regarded as mobile if a portion of the thrombus showed motion independent from that of the adjacent endocardium, which was After discarding the first 2 ml of blood we drew 1-6 ml from the antecubital vein into a precooled silicone coated tube containing 1-0 ml of inhibitor (aprotinin I0 000 U/ml and heparin 500 U/ml). The tube was immediately inverted gently several times and then centrifuged at 2000 g (3000 rpm) for 15 minutes at 4°C. The 1) , nine of which were at the left atrial appendage and the other of which was on the left atrial posterior wall. The remaining eight thrombi were non-mobile (fig 2) , with seven being at the left atrial appendage and the other one being on the left atrial posterior wall. In the remaining 45 patients, there were no intracardiac thrombi (group 2).
The left atrial dimensions of the 10 healthy volunteers and groups 1 and 2 were 27 0 (1-1 mm), 54-6 (1-5) mm, and 52-8 (1-2) mm, respectively. The left atrial dimensions of groups 1 and 2 were significantly larger than those of the controls (p < 0 01), but there was no significant difference between the two groups with mitral stenosis.
Forty four of the 63 patients had atrial fibrillation: 28 (62-2%) without intracardiac thrombi and 16 (88 9%) in those with intracardiac thrombi. There was no significant difference in the incidence of fibrillation between the two groups (X2 test).
COAGULATION STUDIES
Plasma concentrations of fibrinopeptide A, fibrinopeptide Bf15-42, and D-dimer were significantly higher and those of antithrombin III were significantly lower in groups 1 and 2 than in the controls (table). Moreover, the plasma concentrations of fibrinopeptide A and D-dimer in group 1 were significantly higher than those in group 2. There were no significant differences in the haematocrit, prothrombin time, and activated partial thromboplastin time among groups 1 and 2 and the controls.
The plasma concentrations of D-dimer in the patients with mobile thrombi were all above 300 ng/ml (983-3 (242 2) ng/ml) and they were significantly higher than those in the patients with non-mobile thrombi (226-4 (96 3) ng/ml, p < 0 05) (fig 3) . There were no significant differences other than the D-dimer concentration between the patients with and without mobile thrombi.
HISTORY OF EMBOLIC EVENTS
Ofthe 63 patients, 22 had a history ofconfirmed arterial embolism to the brain, kidney (n = 2), or limbs (n = 2) (including four patients with more than one event). All 22 patients had suffered these embolic events more than one month before this study. Nine (3 5) clot and also of the activity of the thrombotic 100 (0-01) 306 (0-6) factors associated with the clot. Hence, even small clots can result in active fibrin deposition and the production of D-dimer, fibrinopeptide A, and fibrinopeptide Bf315-42.
Because blood samples were taken from an antecubital vein our result could have been influenced by thrombosis elsewhere or by emboli from the intracardiac source. However, no patients had a thrombotic disease other than * the intracardiac thrombus or a past history of embolism. In all patients with a history of embolism, the interval between the onset of embolism and the study was more than a month, which is sufficient time for the emboli to have resolved spontaneously.'6 Thus we do not * * believe that such factors are likely to have influenced the results. D-dimer concentrations in the patients with intracardiac mobile thrombi were all above 300 ng/ml, while those in most patients with non-mobile thrombi or without thrombi were below 300 ng/ml. These data suggest that there -was more activation of blood coagulability in * the patients with mobile thrombi than in those with non-mobile thrombi, so mobile clots may be associated with more active fibrin deposition ombus thrombus than non-mobile clots. However, four patients mitral stenosis with non-mobile thrombi or no thrombi had D-dimer concentrations greater than 300 ng/ ml. It is possible that they may have had a mobile thrombus in the left atrium that was smaller than the resolution of our echocarthe other 13 did diograph, or a mobile thrombus at the tip of the 63 patients had left atrial appendage which is difficult to see ism or embolisa-from the transthoracic approach.
In a previous study, we reported on 30 d other diseases, consecutive patients with acute cardiogenic ,renal disease, or cerebral embolism who were examined by e influenced the serial cross sectional echocardiography."7 In nvestigations.
three of the patients who had mitral stenosis and a newly formed mobile thrombus at the left atrial appendage systemic embolism recurred.
In the current study, nine of the 10 patients s a common and with mobile thrombus had a past history of itral stenosis. 1213 embolism whereas none of the eight patients y important as a with non-mobile thrombus had such a history. mbolism. Atrial Thus a mobile thrombus seems to be fresher left atrial dimen-and more liable to be released from the cardiac development of wall to cause systemic emboli. It also seems to our study, there be more likely to regrow. in the incidence In conclusion, high plasma concentrations of left atrial dimen-D-dimer are believed to reflect an intracardiac 1 2. Thus these hypercoagulable state, and measurement of the associated with D-dimer concentration may be useful as a screening method for an increased risk of of fibrinopeptide intracardiac mobile thrombi in patients with Ai TA-;,im.r were mitral stenosis. 
